Etoricoxib-Induced Erythema-Multiforme-Like Eruption

Vol. 216, No. 3, 2008

Free Abstract Article (Fulltext) Article (PDF 168 KB)

Case Report

Etoricoxib-Induced Erythema-Multiforme-Like Eruption
Laurence Thirion, Arjen F. Nikkels, Gérald E. Piérard

Department of Dermatopathology, University Medical Center of Liège, Liège, Belgium

Address of Corresponding Author

Dermatology 2008;216:227-228 (DOI: 10.1159/000112930)

Key Words

Drug reaction
Etoricoxib
Erythema-multiforme-like eruption

Abstract

Etoricoxib is a new, highly selective cyclooxygenase (COX) 2 inhibitor, reported to have an increased cutaneous and systemic safety profile compared to the previous COX-2 inhibitors, including celecoxib, rofecoxib and valdecoxib. To the best of our knowledge, the present case of etoricoxib-induced erythema-multiforme-like eruption is the first reported in the literature.

Author Contacts

Dr. A.F. Nikkels, MD, PhD
Department of Dermatopathology
CHU du Sart-Tilman
BE-4000 Liège (Belgium)
Tel. +32 4 366 2499, Fax +32 4 366 2976, E-Mail af.nikkels@chu.ulg.ac.be

Article Information

Received: June 6, 2007
Accepted: July 24, 2007
Published online: January 9, 2008
Number of Print Pages : 2
Number of Figures : 2, Number of Tables : 0, Number of References : 11

Medline Abstract (ID 18182814)

Download Citation

Cited In

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.